| dc.creator |
Emek, Sevil |
|
| dc.creator |
Kurtoglu, Selim |
|
| dc.creator |
Isguven, Pinar |
|
| dc.creator |
Dizdarer, Ceyhun |
|
| dc.creator |
Pirgon, Ozgur |
|
| dc.creator |
Atabek, Mehmet Emre |
|
| dc.date |
2009-08-31T21:00:00Z |
|
| dc.date.accessioned |
2021-01-21T08:19:20Z |
|
| dc.date.available |
2021-01-21T08:19:20Z |
|
| dc.identifier |
7f78e640-f7ee-469c-881a-face72465d3e |
|
| dc.identifier |
10.1111/j.1399-5448.2008.00497.x |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/7f78e640-f7ee-469c-881a-face72465d3e/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/83777 |
|
| dc.description |
Background: Insulin detemir is a basal insulin analog designed to produce a superior pharmacokinetic profile to basal formulations of human insulin. It has shown consistently improved tolerability ill comparison to neutral protamine Hagedorn (NPH) insulin in adult cohorts, but there are relatively few publications involving pediatric cohorts. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE (TM) observational study |
|
| dc.type |
info:eu-repo/semantics/article |
|